WO2000060062A3 - Human signal transduction serine/threonine protein kinase - Google Patents
Human signal transduction serine/threonine protein kinase Download PDFInfo
- Publication number
- WO2000060062A3 WO2000060062A3 PCT/GB2000/001183 GB0001183W WO0060062A3 WO 2000060062 A3 WO2000060062 A3 WO 2000060062A3 GB 0001183 W GB0001183 W GB 0001183W WO 0060062 A3 WO0060062 A3 WO 0060062A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein kinase
- signal transduction
- threonine protein
- well
- human signal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU35662/00A AU3566200A (en) | 1999-04-01 | 2000-03-28 | Human signal transduction serine/threonine protein kinase |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28395699A | 1999-04-01 | 1999-04-01 | |
US09/283,956 | 1999-04-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000060062A2 WO2000060062A2 (en) | 2000-10-12 |
WO2000060062A3 true WO2000060062A3 (en) | 2001-01-18 |
Family
ID=23088302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/001183 WO2000060062A2 (en) | 1999-04-01 | 2000-03-28 | Human signal transduction serine/threonine protein kinase |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3566200A (en) |
WO (1) | WO2000060062A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7049118B2 (en) | 2001-01-03 | 2006-05-23 | Bayer Healthcare Ag | Regulation of human serine-threonine protein kinase |
WO2003033708A2 (en) * | 2001-10-15 | 2003-04-24 | Bayer Healthcare Ag | Regulation of human serine/threonine protein kinase |
WO2003037910A2 (en) * | 2001-10-30 | 2003-05-08 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
US7482134B2 (en) | 2002-06-05 | 2009-01-27 | Seoul National University Industry Foundation | Signals and molecular species involved in senescence |
RU2345089C2 (en) | 2002-08-06 | 2009-01-27 | Санофи-Авентис Дойчланд Гмбх | PURIFIED 145 kDa-PROTEIN, ABLE TO BIND CHOLESTEROL AND/OR INHIBITORS OF CHOLESTEROL ABSORPTION, METHODS OF ITS OBTAINING AND PURIFICATION AND APPLICATION OF kDa-PROTEIN |
US7364887B2 (en) | 2003-07-18 | 2008-04-29 | Sanofi-Aventis Deutschland Gmbh | Use of PAK inhibitor for the treatment of a joint disease |
EP1498133A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma Deutschland GmbH | Use of a pak inhibitor for the treatment of a joint disease |
US7998688B2 (en) | 2008-03-07 | 2011-08-16 | OSI Pharmaceuticals, LLC | Inhibition of EMT induction in tumor cells by anti-cancer agents |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999053036A2 (en) * | 1998-04-14 | 1999-10-21 | Sugen, Inc. | Ste20-related protein kinases |
-
2000
- 2000-03-28 WO PCT/GB2000/001183 patent/WO2000060062A2/en active Application Filing
- 2000-03-28 AU AU35662/00A patent/AU3566200A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999053036A2 (en) * | 1998-04-14 | 1999-10-21 | Sugen, Inc. | Ste20-related protein kinases |
Non-Patent Citations (8)
Title |
---|
ABO A. ET AL.: "PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia", THE EMBO JOURNAL, vol. 17, no. 22, November 1998 (1998-11-01), pages 6527 - 6540, XP002147782 * |
BAGRODIA S. ET AL.: "Pak to the future", TRENDS IN CELL BIOLOGY, vol. 9, no. 9, September 1999 (1999-09-01), pages 350 - 355, XP000925936 * |
HILLIER L. ET AL.: "The WashU-Merck EST Project; yf64a05.s1 Soares infant brain 1NIB Homo sapiens cDNA clone IMAGE:26963 3', mRNA sequence", EMBL DATABASE ENTRY HS772102; ACCESSION NO. R37772, 4 May 1995 (1995-05-04), XP002147781 * |
HILLIER L. ET AL.: "The WashU-Merck EST Project; ym92f08.r1 Soares adult brain N2b4HB55Y Homo sapiens cDNA clone IMAGE:166407 5', mRNA sequence", EMBL DATABASE ENTRY HS460188; ACCESSION NO. R88460, 24 August 1995 (1995-08-24), XP002147780 * |
NAGASE T ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES. XV. THE COMPLETE SEQUENCES OF 100 NEW CDNA CLONES FROM BRAIN WHICH CODE FOR LARGE PROTEINS IN VITRO", DNA RESEARCH, vol. 6, no. 5, 29 October 1999 (1999-10-29), pages 337 - 345, XP000865804, ISSN: 1340-2838 * |
OHARA O. ET AL.: "Homo sapiens mRNA for KIAA1264 protein, partial cds.", EMBL DATABASE ENTRY AB033090; ACCESSION NO. AB033090, XP002147972 * |
ROE B.A.: "Homo sapiens Chromosome 22q11.2 PAC Clone p201m18 In DGCR Region; complete sequence", EMBL DATABASE ENTRY HSAC97; ACCESSION NO. AC000097, 7 December 1996 (1996-12-07), XP002147852 * |
WILLIAM S.: "Human DNA sequence from clone RP1-80N2 on chromosome 6p24.1-25.3. Contains the gene for MD-1, part of a putative novel gene, ESTs,STSs, GSSs and three putative GpG islands.", EMBL DATABASE ENTRY HS80N2; ACCESSION NO. AL031123, 24 July 1998 (1998-07-24), XP002147853 * |
Also Published As
Publication number | Publication date |
---|---|
AU3566200A (en) | 2000-10-23 |
WO2000060062A2 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4278299A (en) | Human receptor tyrosine kinase | |
US8058242B2 (en) | Chimeric proteins with natriuretic activity | |
EP3307296B1 (en) | Timp2 for use in treating aging-associated conditions | |
US10487113B2 (en) | Peptide having activity to improve skin condition and use thereof | |
PT813545E (en) | Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon | |
WO2000047618A3 (en) | HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES | |
NO985231D0 (en) | Compounds that promote tissue growth | |
WO2002050277A3 (en) | Protein and nucleic acids encoding same | |
WO2000060062A3 (en) | Human signal transduction serine/threonine protein kinase | |
KR101813629B1 (en) | Peptides Having Activities of Skin Condition Improvement and Uses Thereof | |
GB0322645D0 (en) | Use of antisecretory factor peptides | |
EA038283B1 (en) | Method for the treatment or prevention of osteoarthritis | |
AU7610396A (en) | Connective tissue growth factor-3 | |
AU7477201A (en) | Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression | |
WO2005035716A3 (en) | Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof | |
EP4032901A1 (en) | Recombinant human neuregulin derivatives and use thereof | |
ATE410516T1 (en) | VARIANTS OF HUMAN GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE D AND THEIR USES | |
CN113853382A (en) | Novel peptides and uses thereof | |
WO2024031084A3 (en) | Compositions and methods for dye-bound cyclized peptides for medical use | |
WO2001030366A3 (en) | Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases | |
WO2004039978A3 (en) | Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases | |
WO2008077938A1 (en) | Modulators of talin/integrin association and use thereof | |
SE0002417D0 (en) | Promote sequences | |
JP2006282574A (en) | Therapeutic agent for acoustic trauma deafness using anti-cell death activity-enhancing protein fnk | |
EP1640359A3 (en) | Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |